Reduction-Responsive Nucleic Acid Delivery Systems to Prevent In-Stent Restenosis in Rabbits

doi 10.1021/acsami.9b08544.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Stent Placement to Prevent Restenosis After Angioplasty in Small Coronary Arteries

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Lipid Delivery Systems for Nucleic-Acid-Based-Drugs: From Production to Clinical Applications

Pharmaceutics
Pharmaceutical Science
2019English

Stent Thrombosis Distal to the Segment Showing Early In-Stent Restenosis With Everolimus-Eluting Stent

Journal of Cardiology Cases
Cardiovascular MedicineCardiology
2013English

CHA2DS2-VASC Clinical Score to Predict In-Stent Restenosis

Angiology
Cardiovascular MedicineCardiology
2017English

A Novel Mouse Model of In-Stent Restenosis

Atherosclerosis
Cardiovascular MedicineCardiology
2010English

Drug-Eluting Stent Restenosis Rates?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Stenting of Long Femoro-Popliteal Lesions (TASC C and D): A Pilot Study on the Feasibility of the Local Delivery of Paclitaxel and Its Effectiveness to Prevent Restenosis STREAMER (STent REstenosis and Medicaments Release)

Annals of Vascular Surgery
MedicineSurgeryCardiovascular MedicineCardiology
2017English

Homocysteine and Its Effects on In-Stent Restenosis

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Bioreducible Polycations in Nucleic Acid Delivery: Past, Present, and Future Trends

Macromolecular Bioscience
PlasticsPolymersMaterials ChemistryBiomaterialsBioengineeringBiotechnology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy